H. Hacisahinogullari Et Al. , "Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas," JOURNAL FRANCAIS D OPHTALMOLOGIE , vol.45, no.5, pp.511-518, 2022
Hacisahinogullari, H. Et Al. 2022. Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas. JOURNAL FRANCAIS D OPHTALMOLOGIE , vol.45, no.5 , 511-518.
Hacisahinogullari, H., Canturk, Ş., Dogansen, S., & Yarman, S., (2022). Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas. JOURNAL FRANCAIS D OPHTALMOLOGIE , vol.45, no.5, 511-518.
Hacisahinogullari, Hülya Et Al. "Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas," JOURNAL FRANCAIS D OPHTALMOLOGIE , vol.45, no.5, 511-518, 2022
Hacisahinogullari, Hülya Et Al. "Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas." JOURNAL FRANCAIS D OPHTALMOLOGIE , vol.45, no.5, pp.511-518, 2022
Hacisahinogullari, H. Et Al. (2022) . "Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas." JOURNAL FRANCAIS D OPHTALMOLOGIE , vol.45, no.5, pp.511-518.
@article{article, author={Hülya HACİŞAHİNOĞULLARI Et Al. }, title={Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas}, journal={JOURNAL FRANCAIS D OPHTALMOLOGIE}, year=2022, pages={511-518} }